Stay updated on ZW49 Dose Finding in HER2+ Cancers Clinical Trial
Sign up to get notified when there's something new on the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page.

Latest updates to the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added and outdated revision notices (v3.4.1) plus the funding/operating status notice were removed; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding status notice was added and the revision updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page introduces a glossary option and updates metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus the revision tag to v3.4.0. These replacements adjust prior labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision v3.3.4 with minor capitalization and wording changes.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now shown on the page, replacing the previous v3.3.3 tag.SummaryDifference0.0%

- Check64 days agoChange DetectedLocations have been updated and expanded to include sites across California, Florida, Illinois, New York, Pennsylvania, Tennessee, Texas, Virginia, Ontario, and Quebec, with a page revision to v3.3.3 and removal of the HHS Vulnerability Disclosure link.SummaryDifference1%

- Check92 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0 on the page; no substantive changes to study details or related information are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to ZW49 Dose Finding in HER2+ Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZW49 Dose Finding in HER2+ Cancers Clinical Trial page.